MedCity News

05/11/2024

Beam’s Base-Editing Sickle Cell Therapy Shows Early Promise, But a Fatality Overshadows Results

The death wasn’t due to Beam Therapeutics’ sickle cell disease therapy, BEAM-101, but was instead attributed to the preconditioning treatment needed before the genetic medicine is infused. A different Beam program in preclinical development could avoid the need for toxic preconditioning; data fr...

05/11/2024

Dr. Jeff Jacques, Chief Medical Officer of Personify Health highlights payment integrity which helps companies not overpay for health services.

Watch Now: https://ow.ly/3YUp50U0IJZ

05/11/2024

On the latest episode of MedCity's Pivot podcast, Editor-in-Chief, Arundhati Parmar sits down with Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, to discuss how self-insured employers are tackling healthcare challenges. Representing regional coalitions covering 40 million people, Shawn shares insights on the evolving landscape.

Listen Now to learn more about the future of employer-led healthcare: https://ow.ly/zaIZ50U0Fbo

05/11/2024

Chief Strategy Officer Ed Liebowitz discusses the benefits that digital health companies will get by joining the Solera network.

Watch Now: https://ow.ly/HZ6j50U0xBy

05/11/2024

How to Align Primary Care With Behavioral Health

Reimbursement models that align primary care with behavioral health offer low-income provider organizations serving rural Americans and other vulnerable populations an opportunity to enhance coordination and improve outcomes while generating sorely needed revenue.

05/11/2024

Why Retail isn’t the Future of Healthcare

Healthcare must be more than a transactional experience. The focus must be on relationships, continuity, and coordination.

05/11/2024

As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers. You can learn more from Greenway Health about how automation can transform your practice, alleviate burnout, and drive efficiency for both staff and patients. ⬇

https://medcitynews.com/2024/11/reducing-clinical-and-staff-burnout-with-ai-automation/

As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.

05/11/2024

What many of these HR and finance leaders don’t realize is that a bipartisan health insurance program can help companies escape this renewal risk and maintain consistent health insurance costs.

https://ow.ly/ARQb50TZRvN

The status quo is simply untenable for many companies as health insurance costs spiral. From family-owned businesses to large enterprises,...

05/11/2024

5 Interesting Companies I Saw at HLTH

I met a mix of biotech and healthtech companies at HLTH affecting everything from drug development, drug efficacy to controlling specialty care costs and managing chronic diseases.

05/11/2024

"Only through FDA approval can we ultimately make these medicines widely available around the country in a safe manner, not just for veterans and for folks who are suffering from PTSD, but for individuals who are victims of sexual assault, individuals who’ve had traumatic childhoods."

The FDA recently delayed the approval of MDMA-assisted therapy for PTSD, but the VA and states are still taking steps to move along psychedelic medicines, according to a panel of experts at HLTH. That said, it's still important to get FDA approval, they argued.

https://ow.ly/tops50TZRpT

After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there's still a way forward for psychedelic medicines, experts said at HLTH.

05/11/2024

Earlier Detection and Treatment are Essential for Meeting VBC Goals

While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher.

05/11/2024

Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs

The Novo Nordisk/Ascendis partnership’s lead program is once-monthly injectable semaglutide for type 2 diabetes and obesity. This product candidate will be developed with Ascendis Pharma technology that has already yielded two FDA-approved products with longer dosing intervals.

04/11/2024

Is There Still a Place for Point Solutions? One Investor Weighs In

There are some areas where point solutions make a lot of sense, such as when they’re focused on a condition without a lot of comorbidities, according to one healthcare expert.

04/11/2024

John Zutter, CEO of Lantern Care shares what stands out with their Centers for Excellence cancer care over other companies.

Watch Now: https://ow.ly/6p3r50TZG9m

04/11/2024

Viking Therapeutics’ Early Clinical Data Continue to Build Case for Its Oral Obesity Drug

Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ObesityWeek conference. Meanwhile, an injectable version of this Viking drug is on track to Phase 3 testing.

04/11/2024

Why AI Governance Is the Number 1 Issue on This Health System Exec’s Mind

Jason Hill, Ochsner Health’s innovation officer, said he goes to sleep most nights and wakes up most morning worried about one thing: the state of generative AI governance in healthcare. To him, providers and other healthcare organizations are in dire need of frameworks to ensure their AI tools ar...

04/11/2024

CEO of BrightInsight, Kal Patel shares what he thinks the future of digital health will look like in 5 years.

Watch Now: https://ow.ly/4i4C50TZvIY

04/11/2024

INVEST 2025: Connect, Innovate, and Lead in Healthcare Transformation

MedCity’s premier event, INVEST 2025, is taking place April 29-30, 2025, at 333 North Green in the heart of Chicago.

Secure Your Spot at the Best Rate: https://ow.ly/kjgy50TXoV4

04/11/2024

Imaging Practices Can Restore Their Clinicians’ Cybersecurity Confidence With These Four Steps

Steps that healthcare providers can take – internally and with the help of external partners – to boost both their security capabilities and the confidence of their clinicians in those capabilities

04/11/2024

Check out the second part of our Heard at Series: Insights from Innovative Healthcare Executives.

MedCity News talked to executives from Quantum Health, Surescripts, EY, Clinical Architecture, and Personify Health, who shared their approaches to reducing healthcare costs and facilitating digital transformation. You can watch them here: 👇

https://medcitynews.com/2024/11/heard-at-hlth-2024-part-2-insights-from-innovative-healthcare-executives/

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

04/11/2024

Redefining Clinical Development of Obesity Drugs: What Does Success Look Like?

As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers.

04/11/2024

A Recipe for Better Obesity Care: Integrating GLP-1s with Food as Medicine

Nutrition isn’t a supplement — it’s foundational to metabolic health. It’s time we integrate more ‘Food as Medicine’ initiatives alongside the GLP-1 therapies that are gaining traction.

03/11/2024

3 Types of Startups that Healthcare Leaders Want to See More Of

During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to.

03/11/2024

PBGH CEO: Transparency is “Table Stakes” and an “Expectation”

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' challenges in accessing medical data, emphasizing the need for transparency and potential strategies to enhance their fiduciary responsibilities.

03/11/2024

Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs

Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington professor of biochemistry recently awarded the Nobel Prize in Chemistry for his work in computational pr...